Started Feb 15, 2019 06:00PM UTC   •   Closing Oct 01, 2019 06:59AM UTC

Will Bristol-Myers Squibb Corp.’s acquisition of Celgene Corp. close before 1 October 2019? 

On 3 January 2019, pharmaceutical company Bristol-Myers Squibb Corp. announced its planned $74 billion acquisition of biotechnology firm Celgene Corporation, expected by the third quarter of 2019 (CNBC, U.S Securities and Exchange Commission).

Confused? Check our FAQ or ask us for help.

Name Probability
Yes 40%

Sign up or sign in to forecast!

Sign Up Sign In